BUFFALO, N.Y. — One class of drugs that has shown promise in treating diseases ranging from lung cancer to COVID-19 are targeted covalent inhibitors (TCIs). These small molecule drugs form covalent ...
Human cancer cells cultures in the lab of David Heppner. Heppner's team recently found that faster binding for targeted covalent inhibitor drugs was linked to greater potency, but only to a certain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback